Treatment for Generalized Anxiety Disorder
The recommended first-line treatment for generalized anxiety disorder is a combination of cognitive behavioral therapy (CBT) and a selective serotonin reuptake inhibitor (SSRI) medication. 1
Pharmacotherapy Options
First-Line Medications
SSRIs:
SNRIs:
Medication Administration
- Start with lower doses and titrate up gradually:
Important Medication Considerations
- Monitor for side effects:
- Common: nausea, headache, insomnia, sexual dysfunction
- Serious but rare: serotonin syndrome, increased suicidal ideation (especially in young adults)
- Avoid abrupt discontinuation - taper gradually to prevent withdrawal symptoms 2
- Benzodiazepines should only be used short-term due to addiction potential 4
- Screen for bipolar disorder before starting any antidepressant 2
Psychotherapy Options
Cognitive Behavioral Therapy
- Highly effective with response rates between 47-75% 4
- Should follow specific protocols designed for GAD:
Combination Therapy vs. Monotherapy
For adults with GAD:
- Response rates to medication alone: 44-81% 4
- Response rates to CBT alone: 47-75% 4
- Combination therapy (CBT + SSRI) shows superior outcomes in many cases 1
For children and adolescents (6-18 years):
- Combination of CBT and SSRI (particularly sertraline) is superior to either treatment alone for:
- Improved anxiety symptoms
- Better global functioning
- Higher response and remission rates 1
Treatment Algorithm
Initial Treatment:
- Begin with combination of CBT and SSRI (escitalopram 10mg daily or sertraline)
- If CBT is not available, start SSRI alone
- If medication is contraindicated, begin with CBT alone
Evaluation at 4-6 weeks:
- If partial response: optimize SSRI dose
- If minimal/no response: consider switching to another SSRI or SNRI
For Treatment-Resistant Cases:
Special Populations
Children and Adolescents
- For ages 6-18: combination of CBT and SSRI (sertraline preferred) 1
- Start with lower medication doses
- Parental oversight of medication is crucial 1
Elderly Patients
- Use lower doses (10mg/day for escitalopram) 2
- Monitor for drug interactions more carefully
- May need longer titration periods
Common Pitfalls to Avoid
- Prescribing benzodiazepines for long-term management
- Inadequate dose or duration of SSRI trial before declaring treatment failure
- Abrupt discontinuation of medication
- Failure to address comorbid conditions (depression is common)
- Not providing adequate psychoeducation about initial worsening of anxiety with SSRIs
Remember that GAD is often a chronic condition requiring long-term management. Regular reassessment is necessary to determine ongoing treatment needs and to optimize the benefit-to-harm ratio.